Clinical Trial Update: Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq [Phase 3]

View source ↗

Summary

Phase 3 trial update on IGF-1 monitoring in children treated with NutropinAq, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dwarfism
• Pituitary Diseases
• Renal Insufficiency
• Turner Syndrome

Drugs mentioned

• NutropinAq (somatropin)

Snippet

Sponsor: Ipsen | Conditions: Turner Syndrome, Renal Insufficiency, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2018-08-09